Bcl9l Antibodies

AND Bcl9l ELISA kits, Bcl9l Proteins

Many biological assays use antibodies to detect Bcl9l, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with Bcl9l in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop Bcl9l antibodies...

We validate the specificity of these antibodies to Bcl9l by testing them on tissues known to express Bcl9l positively and negatively. Browse below to find the Bcl9l antibody that suites your experiment. We have 3 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: Gpr146

Bcl9l Infographic by Boster Bio

All Bcl9l Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

Anti-BCL9L Antibody Picoband®

1 Q&As

Western blot analysis of BCL9L using anti-BCL9L antibody (A05905)

IHC analysis of BCL9L using anti-BCL9L antibody (A05905)

Human, Mouse, Rat

ELISA, Flow Cytometry, IHC, WB

$370
Cat # A05905
100 μg/vial

Anti-Bcl9L Antibody

Western blot analysis of Bcl9L in HeLa cell lysate with Bcl9L antibody at 1 μg/mL in (A) the absence and (B) the presence of blocking peptide

Immunocytochemistry of Bcl9L in HeLa cells with Bcl9L antibody at 10 μg/mL

Human

ELISA, IF, IHC-P, ICC, WB

$481
Cat # A05905-1
0.1 mg

BCL9L (NM_182557) Human Over-expression Lysate

Human

$960
Cat # LS283149
20 µg, 100 µg

Bcl9l Overview

Facts about B-cell CLL/lymphoma 9-like protein.

B-cell CLL/lymphoma 9-like protein (Bcl9l)

Transcriptional regulator that functions as an activator. Promotes beta-catenin transcriptional activity.

Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1.

Gene Information

Mouse
Gene Name:	Bcl9l
Uniprot:	Q67FY2
Entrez:	80288

Family

Belongs to:

BCL9 family

Alternative Names

B-cell CLL/lymphoma 9-like protein; B-cell CLL/lymphoma 9-like; B-cell lymphoma 9-like protein; Bcl92; Bcl9-2; BCL9-like protein; DLNB11; DLNB11BCL9-2; nuclear co-factor of beta-catenin signalling; Protein BCL9-2

Molecular Weight

Mass (kDA):
156.68 kDA

Genomic Context


Mouse

Location:	9\|9 A5.2
Sequence:	9;

Tissue Specificity

Expressed in kidney, liver, lung, testis, brain, spleen, heart and skeletal muscle. Highly expressed in numerous colorectal tumors compared to corresponding non-cancerous tissues.

Diseases

Malignant Neoplasms
Neoplasms
Carcinogenesis
Neuroblastoma
Colorectal Neoplasms
Cell Transformation, Neoplastic
Adenoma
Carcinoma
Mammary Neoplasms
Adenocarcinoma
Malignant Paraganglionic Neoplasm
Neoplasm Metastasis
Embryonal Carcinoma

Non-neoplastic Disorder
Tumor Progression
Colonic Neoplasms
Malignant Tumor Of Colon
Ulcer
Invasive Ductal Breast Carcinoma
Carcinoma In Situ

Pathways

Regeneration
Tissue Homeostasis
Tissue Regeneration
Stem Cell Maintenance
Immune Response
Neurogenesis
Cell Fate Determination

Localization
Chromosome Segregation

PTMs

Phosphorylation

Methylation

Ubiquitination

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/Bcl9l

References

PMID: 15574752 by Adachi S., et al. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.

PMID: 15371335 by Brembeck F.H., et al. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.